T Cell-Mediated Hepatic Injury Mechanisms

T cells are central to the pathogenesis of various forms of liver injury. Upon antigen presentation by hepatocytes or non-parenchymal antigen-presenting cells such as Kupffer cells and liver sinusoidal endothelial cells, naive T cells differentiate into effector subsets. CD8+ cytotoxic T lymphocytes mediate hepatocyte damage via perforin/granzyme release and FAS ligand interactions, whereas CD4+ Th1 cells secrete pro-inflammatory cytokines such as interferon-γ and tumour necrosis factor-α. Chronic activation of T cells also drives oxidative stress, apoptotic signalling and stellate cell activation, thereby promoting fibrogenesis. Interactions between T cells and resident hepatic cells create a microenvironment that modulates tolerance and inflammation in response to viral infection, autoimmune triggers or toxic insults. Dysregulation of regulatory T cells contributes to the breakdown of self-tolerance in autoimmune hepatitis. Understanding the molecular mechanisms governing T cell activation, trafficking and effector functions is critical for developing targeted immunomodulatory therapies with broad applications from viral hepatitis to drug-induced liver injury.

Research from Nature Portfolio

No recent Nature Portfolio content available.

T Cell-Mediated Hepatic Injury Mechanisms publication trend

The graph below shows the total number of articles in t cell-mediated hepatic injury mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Concanavalin A (Con A): A plant lectin used experimentally to activate T cells and induce immune-mediated liver injury.

Interferon-γ (IFN-γ): A cytokine produced by Th1 and CD8+ T cells that drives inflammation and hepatocyte apoptosis.

JAK2/STAT1 pathway: A cytokine-activated signalling cascade that promotes transcription of genes involved in apoptosis and inflammation.

Toll-like receptor 4–NF-κB signalling: A pathway whereby TLR4 activation leads to NF-κB nuclear translocation and the expression of pro-inflammatory mediators.

Nrf2/HO-1 pathway: A cellular defence mechanism against oxidative stress that upregulates antioxidant gene expression to protect tissues.

Autophagy: A regulated process of intracellular degradation that can influence cell survival or death under stress conditions.

References

1. Enhancing Liver Delivery of Gold Nanoclusters via Human Serum Albumin Encapsulation for Autoimmune Hepatitis Alleviation. Pharmaceutics (2024).
2. A low dose of naloxone mitigates autoimmune hepatitis by regulating TLR4/NF-κB and Nrf2/HO-1 signaling pathways. Inflammopharmacology (2023).
3. Protective Effects of Astaxanthin on ConA-Induced Autoimmune Hepatitis by the JNK/p-JNK Pathway-Mediated Inhibition of Autophagy and Apoptosis. PLOS ONE (2015).